Physician
Oncology
Dr. Elizabeth J. Shpall, MD
|
|
Give Review
Elizabeth Shpall is an expert in the field of Oncology. She went to medical school at Mount Sinai School of Medicine. Elizabeth Shpall is a published doctor and has 101 publications published. The lastest was: 'Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.' She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Utility of the ELISPOT interferon-γ release assay to predict the risk of CMV infection in hematopoietic Cell transplant recipients.
- Treg adoptive therapy: is more better?
- Autologous hematopoietic stem Cell transplantation in light chain amyloidosis (AL) with renal involvement.
- Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.
- Adoptive immunotherapy for primary immunodeficiency Disorders with virus-specific T lymphocytes.
- Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
- Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
- Expression of a Surface Antigen (MA6) by Peripheral Blood CD34(+) Cells Is Correlated with Improved Platelet EnGraftment and May Explain Delayed Platelet EnGraftment F...
- Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet enGraftment after transplantation.
- Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed Myeloma.
- Shifting paradigms in the treatment of chronic lymphocytic Leukemia.
- General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.
- Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hemato...
- Advances in umbilical cord blood manipulation-from niche to bedside.
- Effect of Cord Blood Processing on Transplant Outcomes after Single Myeloablative Umbilical Cord Blood Transplantation.
- Phenotypic and functional comparison of mobilized peripheral blood versus umbilical cord blood megakaryocyte populations.
- Ex vivo fucosylation of 3rd party human regulatory T cells enhances anti-Graft versus host disease potency in vivo.
- Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future.
- Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen-Matched Unre...
- Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in Chronic GVHD.
- Progress in Novel Cellular Therapy Options for Chronic Lymphocytic Leukemia: The MD Anderson Perspective.
- Transmissible cytotoxicity of multiple Myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking.
- Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple Myeloma.
- Cytogenetics, Donor Type, and Use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation.
- Is there an expiration date for a cord blood unit in storage?
- FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T Cells.
- Increasing Chimerism Following Allogeneic Stem Cell Transplantation is Associated with Longer Survival Time.
- Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic Leukemia cells.
- Reciprocal Leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
- Low rate of infusional toxicity after expanded cord blood transplantation.
- The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.
- Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic Graft-versus-host disease.
- The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
- Does plerixafor destroy the hematopoietic progenitor Cell/mesenchymal stromal Cell niche?
- Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant.
- Extracorporeal photopheresis in the treatment of Graft-versus-host disease: evidence and opinion.
- Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood enGraftment.
- CD4(-)/CD8(-) Variant of T-Cell Large Granular Lymphocytic Leukemia or Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Dilemma.
- Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to...
- Infusion of donor-derived CD19-redirected-virus-specific T cells for B-cell Malignancies relapsed after allogeneic stem cell transplant: a phase I study.
- Impact of t(11;14)(q13;q32) on the Outcome of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients w...
- Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates Leukemia bone marrow engraftment.
- Outcomes of adults with Acute lymphoblastic leukemia (ALL) following relapse post allogeneic hematopoietic stem cell transplantation (HSCT).
- Multicenter study of banked third party virus-specific T-Cells to treat severe viral infections after hematopoietic stem Cell transplantation.
- Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.
- Generation of multi-Leukemia antigen-specific T cells to enhance the graft-versus-Leukemia effect after allogeneic stem cell transplant.
- Clinical application of sleeping beauty and artificial antigen presenting Cells to genetically modify T Cells from peripheral and umbilical cord blood.
- Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC.
- Cord blood Graft engineering.
- Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with Acute leukemia.
- Umbilical cord blood transplantation: a maturing technology.
- Cord-blood enGraftment with ex vivo mesenchymal-cell coculture.
- CARs in Chronic Lymphocytic Leukemia - Ready to Drive.
- Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients.
- Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome.
- High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid Malignancies.
- Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with Acute lymphoblastic leukemia.
- Bayesian continual reassessment method for dose-finding trials infusing T Cells with limited sample size.
- Conserved DNA methylation patterns in healthy blood cells and extensive changes in Leukemia measured by a new quantitative technique.
- Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive Cells.
- Regulation of HIF-1α signaling and chemoresistance in Acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplant.
- Reply to sackstein.
- Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell...
- Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
- Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Ty...
- High-dose chemotherapy with autologous stem cell transplant for Breast cancer: what have we learned 25 years later?
- Infusing CD19-directed T cells to augment Disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.
- Fludarabine, Melphalan, Thiotepa and ATG Conditioning for Unrelated Cord Blood Transplantation.
- HLA matching of CB: it's complicated.
- Donor-specific anti-HLA antibodies and Graft failure in matched unrelated donor hematopoietic stem cell transplantation.
- Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin Lymphoma: pre...
- Ex vivo Graft purging and expansion of autologous blood progenitor cell products from patients with Multiple Myeloma.
- Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement.
- Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem Cell transplantation in patients with advanced lympho...
- Prophylaxis of Graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively ra...
- Steroid-Refractory Acute GVHD: Predictors and Outcomes.
- Novel cord blood transplant therapies.
- The 2011 education supplement on hematopoietic stem Cell transplantation.
- Lymphocyte recovery predicts outcomes in cord blood and T Cell-depleted haploidentical stem Cell transplantation.
- Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission.
- Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid Leukemia and MDS.
- Cord blood natural killer Cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.
- Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem Cell transplantation.
- piggyBac transposon/transposase System to generate CD19-specific T cells for the treatment of B-lineage malignancies.
- Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infectio...
- A phase III study of infliximab and corticosteroids for the initial treatment of Acute graft-versus-host disease.
- High risk of Graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
- Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of Acute graft-versus-host disease.
- NK antibody therapy: KIR-ative intent.
- Functionally active virus-specific T Cells that target CMV, adenovirus, and EBV can be expanded from naive T-Cell populations in cord blood and will target a range of ...
- Noninvasive bioluminescent imaging demonstrates long-term multilineage enGraftment of ex vivo-expanded CD34-selected umbilical cord blood cells.
- Endpoints for clinical trials testing treatment of Acute graft-versus-host disease: a joint statement.
- Repetitive noninvasive monitoring of HSV1-tk-expressing T Cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography...
- Low-dose azacitidine after allogeneic stem cell transplantation for Acute leukemia.
- Th-1 polarization is regulated by dendritic-Cell comparison of MHC class I and class II antigens.
- High-dose chemotherapy for high-risk primary and metastatic Breast cancer: is another look warranted?
- Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic Malignancies.
- Cord blood stem Cell therapy for acquired immune deficiency syndrome.
Schools
Univ Of Cincinnati Coll Of Med
Beth Israel Med Center
Mt Sinai Hospital
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Breast Cancer
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Mount Sinai School of Medicine -
Mount Sinai Beth Israel -
University of Cincinnati College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1326139098 | |
| NPPES Provider LastName | SHPALL | |
| NPPES Provider FirstName | ELIZABETH | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 570.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326139098 |
| Last Name Of The Provider | SHPALL |
| First Name Of The Provider | ELIZABETH |
| View All |
Similar Doctors
|
|
Dr. Andrea L. Dean, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shagufta N. Naqvi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth W. Rogg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Powel H. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vassiliki A. Papadimitrakopoulou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Ellerhorst, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Isabella C. Glitza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donna S. Zhukovsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miloslav I. Beran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yan Zhou, MD
This Doctor is OpenDoctor Recommended.
|